Cambridge Nutritional Sciences plc provided earnings guidance for the year ended 31 March 2024. for the year, the company expects revenue of £9.8 million (2023: £7.5 million) representing 30% growth.
Cambridge Nutritional Sciences plc
Equities
ODX
GB00B1VCP282
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.9 GBX | 0.00% | -1.27% | +62.50% |
04-22 | Cambridge Nutritional Sciences Nonexecutive Chair Steps Down; Successor Named | MT |
04-22 | Cambridge Nutritional Sciences plc Provides Earnings Guidance for the Year Ended 31 March 2024 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+62.50% | 11.59M | |
-1.34% | 12.58B | |
-1.64% | 8.51B | |
+0.09% | 5.29B | |
+21.68% | 5.16B | |
-0.09% | 4.55B | |
-52.34% | 3.04B | |
+20.02% | 3B | |
+29.47% | 2.17B | |
-2.45% | 1.92B |
- Stock Market
- Equities
- ODX Stock
- News Cambridge Nutritional Sciences plc
- Cambridge Nutritional Sciences plc Provides Earnings Guidance for the Year Ended 31 March 2024